Stocks Set To Open Up
Stocks are set to open higher Friday.
Pediatrix Medical
(
PDX |
Quote |
Chart |
News |
PowerRating) reaffirmed
its Q4 outlook of 39 cents to 40 cents a share. The company also announced that
it has settled a securities class action lawsuit.
Goldman Sachs lowered estimates on
CIENA
(
CIEN |
Quote |
Chart |
News |
PowerRating) after the company lowered FY02 revenues and earnings
yesterday. Goldman lowered estimates to $1 billion, or 28 cents a share,
from $1.58 billion, or 40 cents a share.
Bristol-Myers
(
BMY |
Quote |
Chart |
News |
PowerRating) was upgraded
by Goldman Sachs from Market Outperform to Trading Buy.
Robertson Stephens downgraded KPMG
Consulting
(
KCIN |
Quote |
Chart |
News |
PowerRating) from Market Perform to Market Underperform.
Microtune
(
TUNE |
Quote |
Chart |
News |
PowerRating) priced 7 million
shares in a secondary offering at $23 per share.
ABN Amro downgraded BEI Technologies
(
BEIQ |
Quote |
Chart |
News |
PowerRating)
from Add to Hold due to a short-term negative outlook.
Robertson Stephens upgraded Celera
Genomics
(
CRA |
Quote |
Chart |
News |
PowerRating) from Market Perform to Buy, citing the company has made
significant progress in becoming a fully integrated drug discovery company from
a genomics database provider.
Quest Diagnostics
(
DGX |
Quote |
Chart |
News |
PowerRating) was
granted non-exclusive license from Orchid Biosciences
(
ORCH |
Quote |
Chart |
News |
PowerRating) for the
company’s use of ORCH’s proprietary SNP-IT technology.
Aetna
(
AET |
Quote |
Chart |
News |
PowerRating) said it will slash
6000 jobs and will take a Q4 charge of $125 million to cover the cuts.
The CPI number for November was
unchanged. However, the core rate increase 0.4%, which was higher than expected.